Benjamin Salzer

906 total citations
15 papers, 445 citations indexed

About

Benjamin Salzer is a scholar working on Oncology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Benjamin Salzer has authored 15 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Benjamin Salzer's work include CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (6 papers) and Virus-based gene therapy research (5 papers). Benjamin Salzer is often cited by papers focused on CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (6 papers) and Virus-based gene therapy research (5 papers). Benjamin Salzer collaborates with scholars based in Austria, United States and United Kingdom. Benjamin Salzer's co-authors include Manfred Lehner, Charlotte U. Zajc, Michael W. Traxlmayr, Peter Pietschmann, Susanna Skalicky, Florian Hildner, Christian Gabriel, Matthias Hackl, Johannes Grillari and M. Wagner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.

In The Last Decade

Benjamin Salzer

14 papers receiving 439 citations

Peers

Benjamin Salzer
Katheryn Begg United Kingdom
Benjamin Salzer
Citations per year, relative to Benjamin Salzer Benjamin Salzer (= 1×) peers Katheryn Begg

Countries citing papers authored by Benjamin Salzer

Since Specialization
Citations

This map shows the geographic impact of Benjamin Salzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Salzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Salzer more than expected).

Fields of papers citing papers by Benjamin Salzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Salzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Salzer. The network helps show where Benjamin Salzer may publish in the future.

Co-authorship network of co-authors of Benjamin Salzer

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Salzer. A scholar is included among the top collaborators of Benjamin Salzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Salzer. Benjamin Salzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Peters, Timo, Benjamin Salzer, Janett Göhring, et al.. (2024). TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation. Science Advances. 10(36). eadj4632–eadj4632. 1 indexed citations
2.
Zajc, Charlotte U., Benjamin Salzer, Elisabeth Laurent, et al.. (2024). An engineering strategy to target activated EGFR with CAR T cells. Cell Reports Methods. 4(4). 100728–100728. 12 indexed citations
3.
Salzer, Benjamin, et al.. (2023). Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors. Proceedings of the National Academy of Sciences. 120(2). e2216352120–e2216352120. 31 indexed citations
4.
Leitner, Judith, Marlene C. Gerner, Benjamin Salzer, et al.. (2023). Interrogating ligand-receptor interactions using highly sensitive cellular biosensors. Nature Communications. 14(1). 7804–7804. 4 indexed citations
5.
Linhares, Annika De Sousa, Benjamin Salzer, Manfred Lehner, et al.. (2023). The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif. Science Signaling. 16(805). eadg2610–eadg2610. 9 indexed citations
6.
Salzer, Benjamin, et al.. (2022). Preclinical testing of CAR T cells in zebrafish xenografts. Methods in cell biology. 167. 133–147.
7.
Laurent, Elisabeth, Benjamin Salzer, Manfred Lehner, et al.. (2021). Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synthetic Biology. 10(5). 1184–1198. 8 indexed citations
8.
Zajc, Charlotte U., Irene Schaffner, Georg Mlynek, et al.. (2020). A conformation-specific ON-switch for controlling CAR T cells with an orally available drug. Proceedings of the National Academy of Sciences. 117(26). 14926–14935. 69 indexed citations
9.
Salzer, Benjamin, Charlotte U. Zajc, Timo Peters, et al.. (2020). Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function. Nature Communications. 11(1). 4166–4166. 68 indexed citations
10.
Zajc, Charlotte U., Benjamin Salzer, Joseph M. Taft, et al.. (2020). Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds. FEBS Journal. 288(7). 2103–2118. 31 indexed citations
11.
Lobner, Elisabeth, Venugopal Gudipati, Patrick Mayrhofer, et al.. (2020). Getting CD19 Into Shape: Expression of Natively Folded “Difficult-to- Express” CD19 for Staining and Stimulation of CAR-T Cells. Frontiers in Bioengineering and Biotechnology. 8. 49–49. 11 indexed citations
12.
Byrgazov, Konstantin, Benjamin Salzer, Eva Bozsaky, et al.. (2020). Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide. Therapeutic Advances in Medical Oncology. 12. 3863552931–3863552931. 7 indexed citations
13.
Salzer, Benjamin, Andrea Wenninger-Weinzierl, Caterina Sturtzel, et al.. (2020). A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in Vivo. Cancers. 12(3). 567–567. 23 indexed citations
14.
Zajc, Charlotte U., Benjamin Salzer, Markus Münz, et al.. (2018). A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells. Scientific Reports. 8(1). 17453–17453. 11 indexed citations
15.
Weilner, Sylvia, Susanna Skalicky, Benjamin Salzer, et al.. (2015). Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation. Bone. 79. 43–51. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026